C.B. Fleet Company, Inc. (Fleet Laboratories), a portfolio company of Gryphon Investors, has been sold to Prestige Brands Holdings, Inc. Financial details have not been disclosed.
C.B. Fleet Company, Inc., also known as Fleet Laboratories, manufactures and markets consumer health, beauty, and over-the-counter pharmaceutical products for consumers and healthcare professionals worldwide. It offers gastrointestinal care products for bowel cleansing, and relief of constipation and gas symptoms, feminine health and hygiene products, and infant care products.
Prestige Brands is the largest independent provider of over-the-counter products in North America providing detailed attention to each and every one of its product offerings. Prestige is constantly improving, creating products that match the ever-changing lifestyles and needs of people and families everywhere.
Founded in 1995 and based in San Francisco, Gryphon Investors focuses on leveraged acquisitions of, and growth investments in, middle-market companies in partnership with experienced management teams. With more than US$1.4 billion of cumulative equity commitments, Gryphon has an extensive track record of investing up to US$100 million of its committed capital per investment in companies with sales ranging from approximately US$100 to 500 million.
One of Oaklins' teams in the USA served as a financial advisor to C.B. Fleet Company, a portfolio company of Gryphon Investors, in its sale to Prestige Brands.
W. Gregory Robertson
© 2018 Oaklins. All rights reserved. Oaklins is the collective trade name of independent member firms affiliated with Oaklins International Inc. For details of the nature of affiliation, please refer to www.oaklins.com/legal.